No Data
No Data
No Data
No Data
No Data
Establishment Labs Announces Participation in The Aesthetic Meeting 2024
Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced its
BusinesswireApr 17 08:30 ET
Establishment Labs Is Maintained at Buy by Citigroup
Establishment Labs Is Maintained at Buy by Citigroup
Dow JonesApr 3 11:56 ET
Citigroup Maintains Buy on Establishment Labs Hldgs, Raises Price Target to $60
Citigroup analyst Joanne Wuensch maintains Establishment Labs Hldgs (NASDAQ:ESTA) with a Buy and raises the price target from $49 to $60.
BenzingaApr 3 11:46 ET
Analysts Offer Insights on Healthcare Companies: Establishment Labs Holdings (ESTA) and Gritstone Oncology (GRTS)
TipRanksApr 3 05:32 ET
Establishment Labs Says US FDA Schedules Preapproval Inspection of Motiva Implants Facility
Establishment Labs (ESTA) said Tuesday that the US Food and Drug Administration scheduled a PMA preapproval inspection of the company's manufacturing facility for Motiva Implants. The inspection is se
MT NewswiresApr 2 11:47 ET
Establishment Labs Is Maintained at Buy by Mizuho
Establishment Labs Is Maintained at Buy by Mizuho
Dow JonesApr 1 07:59 ET
No Data
No Data